Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/30/2003WO2002077029A3 Cd19-specific redirected immune cells
05/30/2003WO2002076499A3 Combination treatment of pancreatic cancer
05/30/2003WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002064214A3 Anti cancer combination of substituted pyrroles and paclitaxel
05/30/2003WO2002064132A3 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
05/30/2003WO2002059293A3 Process and compositions for peptide, protein and peptidomimetic synthesis
05/30/2003WO2002058624A3 In situ generation allicin for the treatment of cancer and infectious diseases
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002036816A3 Method of determining susceptibility to diseases
05/30/2003WO2002036160A3 Method for obtaining antigenic structures enhancing specific cross reactivity
05/30/2003WO2002034291A3 Compositions and methods for treating hematologic malignancies and multiple drug resistance
05/30/2003WO2002034244A3 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001092542A3 Integrin-targeting vectors having enhanced transfection activity
05/30/2003WO2001091792A3 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
05/30/2003WO2001052874A9 Intra-tumoral administration of il-12 encoding nucleic acid molecules
05/30/2003CA2506616A1 Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
05/30/2003CA2468170A1 Method for identification of tumor targeting enzymes
05/30/2003CA2468107A1 Methods for identifying and validating potential drug targets
05/30/2003CA2468046A1 Novel tetronic acid derivative
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467908A1 Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467559A1 Topical delivery of codrugs
05/30/2003CA2467242A1 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467053A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003CA2467020A1 Tumor specific monoclonal antibodies
05/30/2003CA2466986A1 Pharmaceutical formulation comprising bicalutamide
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/30/2003CA2465807A1 Use of bisindolmaleimide and gemcitabine for the treatment of cancer
05/30/2003CA2464542A1 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/29/2003US20030101466 Method for screening for agents against cancer using an immunosuppression animal model
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100597 Novel indole derivatives and their use as medicaments
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100577 Neurotrophic agents in treatment of solid tumors and vascular disease
05/29/2003US20030100576 Methods and compounds for inhibiting mrp1
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100567 Tyrosine kinase inhibitors
05/29/2003US20030100564 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100557 LPAAT-beta inhibitors and uses thereof
05/29/2003US20030100555 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/29/2003US20030100553 Farnesyl protein transferase inhibitor combinations with camptothecin compounds
05/29/2003US20030100551 Production of apoptotic films for direct contact with tumors
05/29/2003US20030100548 Antiarthritic agents; atherosclerosis and chronic obstructive pulmonary disease treatments
05/29/2003US20030100538 Substituted chalcones as therapeutic compounds
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100115 Killing cells that lack tumor suppressor proteins; obtain cells, transform with preferential single stranded nucleotide sequence, monitor viability of cells
05/29/2003US20030100034 Detection of modulators of cell activity; obtain cell, incubate with modulator, measure the concentration of target polypeptide, evaluate for cancer
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099765 Process for coating a surface of a stent
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099728 Anti-aromatase composition
05/29/2003US20030099725 For therapy and prophylaxis of cancers especially cancer of lung, esophagus, stomach, oral cavity and prostate as well as for therapy of Helicobacter pylori infection; useful as adjuncts to conventional surgery or radiotherapy
05/29/2003US20030099719 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
05/29/2003US20030099718 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity
05/29/2003US20030099697 Amphoteric liposomes and their use
05/29/2003US20030099686 Theobromine with an anti-carcinogenic activity
05/29/2003US20030099675 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099662 Proteins
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099619 Method and composition for targeting an adenoviral vector
05/29/2003US20030099614 2-Methoxyestradiol-induced apoptosis in cancer cells
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099600 Metalloproteinase inhibitors for the treatment of respiratory diseases
05/28/2003EP1314741A1 Bispecific anti-CD19 x anti-CD16 antibodies and uses thereof
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
05/28/2003EP1314438A1 Anti-proliferative composition
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313875A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313855A2 Truncated bard1 protein, and its diagnostic and therapeutic uses
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313844A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313839A1 Immune potentiating compositions
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313768A2 Antisense oligonucleotides against vr1
05/28/2003EP1313738A1 Process for the preparation and purification of thiol-containing maytansinoids
05/28/2003EP1313737A1 Novel guanidino derivatives as inhibitors of cell adhesion
05/28/2003EP1313734A2 Aza heterocyclic derivatives and their therapeutic use
05/28/2003EP1313732A1 Oxindole derivatives
05/28/2003EP1313727A1 Quinazoline derivatives
1 ... 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 ... 2211